基因组学市场规模、份额和成长分析：按产品/服务、最终用户、研究类型、地区 - 产业预测，2024-2031

2022年基因组学市场规模将为278.1亿美元，从2023年的332.5亿美元增长到2031年的4113.5亿美元，在预测期内（2024-2031年）预计复合年增长率为19.4%。

基因组学是对基因组的研究，重点是研究生物 DNA 的结构、功能、演化和图谱。该领域对人类生活产生重大影响，并透过基因组学革命推动医学和生物医学的快速变革。全球癌症发生率不断上升，导致政府加大了基因组学计划的津贴。透过人类基因组的研究使个人化医疗的概念成为可能，它彻底改变了临床肿瘤学和罕见遗传疾病的治疗。学术界越来越多地研究遗传学和认知障碍之间的联繫，以更好地了解大脑在这些疾病中的作用。由于癌症和癌症治疗研究的扩大、对快速且易于理解的临床诊断的需求不断增加以及政府机构和生物製药公司对研发的投资增加，基因组学市场正在经历快速的收益成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• Start-Ups分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 市场魅力指数
• 竞争程度

基因组市场：依产品/服务分类

• 市场概况
• 耗材/试剂
• 服务
• 设备、系统、软体

基因组学市场：依技术分类

• 市场概况
• 定序
• PCR
• 流式细胞技术
• 微阵列
• 其他技术

基因组学市场：依应用分类

• 市场概况
• 药物发现/开发
• 诊断
• 农业/动物研究
• 其他用途

基因组学市场：依研究类型

• 市场概况
• 功能基因体学
• 生物标记发现
• 通路分析
• 表观基因
• 其他研究类型

基因组学市场：依最终用户分类

• 市场概况
• 医院/诊所
• 学术/研究机构
• 製药和生物技术公司
• 其他最终用户

基因组学市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Illumina, Inc.（US）
• Thermo Fisher Scientific（US）
• Qiagen NV（Netherlands）
• BGI Group（China）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（US）
• Pacific Biosciences of California, Inc.（US）
• Oxford Nanopore Technologies, Ltd.（United Kingdom）
• Agilent Technologies, Inc.（US）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（US）
• Myriad Genetics, Inc.（US）
• Fluidigm Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• Natera, Inc.（US）
• Veracyte, Inc.（US）
• Personalis, Inc.（US）
• 10x Genomics, Inc.（US）
• Quest Diagnostics（US）

Genomics Market size was valued at USD 27.81 billion in 2022 and is poised to grow from USD 33.25 billion in 2023 to USD 411.35 billion by 2031, growing at a CAGR of 19.4% in the forecast period (2024-2031).

Genomics involves the study of genomes, focusing on the structure, function, evolution, and mapping of an organism's DNA. This field has significantly impacted human life, driving a rapid transformation in medicine and biomedical sciences due to the genomics revolution. The rising global incidence of cancer has prompted increased government support through grants for genomics projects. The concept of personalized medicine, made possible by studying the Human Genome, has revolutionized clinical oncology and the treatment of rare genetic disorders. Academics are increasingly investigating the connection between genetics and cognitive disorders to better understand the brain's role in these conditions. The genomics market is experiencing rapid revenue growth due to the expanding research on cancer and cancer therapies, the growing demand for quick and straightforward clinical diagnoses, and the increased investment in R&D by government organizations and biopharmaceutical companies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genomics Market Segmental Analysis

The genomics market is segmented into Product & Service, Technology, Study Type, Application, End Use, and Region. Based on Product and Service, the market is segmented into Consumables and Reagents, Services, Instruments, Systems, and Software. Based on Technology, the market is segmented into Sequencing, PCR, Genomics, Microarrays, Other Technologies. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, and Other Study Types. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other Applications. Based on End User, the market is segmented into Government and Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Users. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Genomics Market

The genomics market is being propelled by the expanding application of Next-Generation Sequencing (NGS) in cancer research. NGS technologies are increasingly utilized for whole-genome sequencing, genome diversity studies, metagenomics, epigenetics, non-coding RNA discovery, protein-binding site identification, and RNA sequencing for gene expression profiling. These diverse applications of NGS are significantly contributing to the growth of the genomics market.

Restraints in the Global Genomics Market

The genomics market is experiencing a growing demand for a skilled genetic workforce. However, a potential limitation is the availability of competent personnel. Additionally, the high cost of genomic equipment and challenges related to data storage for sequenced data from 2023 to 2031 are expected to impact market growth. Integrating genomic approaches and technologies into healthcare systems holds promise for enhancing safety, quality, efficiency, and cost-effectiveness. Nevertheless, achieving these benefits largely depends on the availability of skilled professionals.

Market Trends of the Global Genomics Market

Organizations using the Illumina OmniExpress chip, such as Ancestry.com, will need to transition to the customized Illumina Global Screening Array (GSA) microarray, as the OmniExpress chip will be phased out. This shift will compel these organizations to either adopt the GSA chip, switch to Thermo Fisher Scientific products, or implement next-generation sequencing technology to maintain their operations.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Start-up Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Genomics Market by Product & Service

• Market Overview
• Consumables and Reagents
• Services
• Instruments, Systems, and Software

Genomics Market by Technology

• Market Overview
• Sequencing
• PCR
• Flow Cytometry
• Microarrays
• Other Technologies

Genomics Market by Application

• Market Overview
• Drug Discovery and Development
• Diagnostics
• Agriculture and Animal Research
• Other Applications

Genomics Market by Study Type

• Market Overview
• Functional Genomics
• Biomarker Discovery
• Pathway Analysis
• Epigenomics
• Other Study Types

Genomics Market by End User

• Market Overview
• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

Genomics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies, Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments